NCT05884333
- Conditions
- Acute Lymphoblastic Leukemia (ALL), Acute Myelogenous Leukemia (AML), Bone Marrow Diseases, +26 more
- Locations
-
- Memorial Sloan Kettering Cancer Center New York, United States
Clinical trial condition
Chronic Myelogenous Leukemia (CML)
Explore clinical trials studying Chronic Myelogenous Leukemia (CML). Study availability and eligibility vary by location and protocol.
11 public trials
2 recruiting studies
Chronic Myelogenous Leukemia (CML) trial results
Recruiting
A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)
NCT01351545
- Conditions
- Acute Lymphoblastic Leukemia (ALL), Acute Myelogenous Leukemia (AML or ANLL), Anemia, +43 more
- Locations
-
- University of Alabama at Birmingham Birmingham, Alabama, United States
- Banner MD Anderson Cancer Center Gilbert, Arizona, United States
- Phoenix Children's Hospital Phoenix, Arizona, United States
- Mayo Clinic Arizona (adults) Phoenix, Arizona, United States
Completed
Bone Marrow and Kidney Transplant for Patients With Chronic Kidney Disease and Blood Disorders
NCT01758042
- Conditions
- AL Amyloidosis, Acute Lymphoblastic Leukemia (ALL), Acute Myeloid Leukemia (AML), +73 more
- Locations
-
- Massachusetts General Hospital Boston, Massachusetts, United States
NCT02730299
- Conditions
- Acute Leukemia, Acute Lymphoblastic Leukemia (ALL), Acute Myelogenous Leukemia (AML), +27 more
- Locations
-
- UCLA Los Angeles, California, United States
- City of Hope Los Angeles, California, United States
- Stanford University Cancer Institute Palo Alto, California, United States
- UC San Diego Moores Cancer Center San Diego, California, United States
NCT03959241
- Conditions
- Acute Leukemia, Anemia, Anemia, Refractory, +22 more
- Locations
-
- University of Alabama at Birmingham Birmingham, Alabama, United States
- City of Hope National Medical Center Duarte, California, United States
- University of California, San Francisco San Francisco, California, United States
- Stanford Hospital and Clinics Stanford, California, United States
NCT01735955
- Conditions
- Acute Lymphoblastic Leukemia (ALL), Albinism, Amino Acid Metabolism, Inborn Errors, +41 more
- Locations
-
- Novartis Investigative Site Albany, New York, United States
- Novartis Investigative Site Houston, Texas, United States
- Novartis Investigative Site Vienna, Austria
- Novartis Investigative Site Vancouver, British Columbia, Canada
NCT01768845
- Conditions
- Acute Lymphocytic Leukemia (ALL), Acute Myelogenous Leukemia (AML), Anemia, +42 more
- Locations
-
- West Virginia University Hospitals Mary Babb Randolph Cancer Center Morgantown, West Virginia, United States
Completed
IL-15 Super Agonist ALT-803 to Treat Relapse Of Hematologic Malignancy After Allogeneic SCT
NCT01885897
- Conditions
- Acute Lymphoblastic Leukemia (ALL), Acute Myelogenous Leukemia (AML), Bone Marrow Diseases, +28 more
- Locations
-
- Masonic Cancer Center, University of Minnesota Minneapolis, Minnesota, United States
- Washington University St Louis, Missouri, United States
- University of Pennsylvania Philadelphia, Pennsylvania, United States
NCT01243489
- Conditions
- Behavior, Bone Marrow Diseases, Chromosome Aberrations, +19 more
- Locations
-
- Onkologische Schwerpunktpraxis Celle Celle, Germany
- Onkozentrum Dresden, Gemeinschaftspraxis Dres. Göhler & Dörfel Dresden, Germany
- Gemeinschaftspraxis Hämatologie - Onkologie, BAG Freiberg-Richter / Jacobasch / Illmer / Wolf Dresden, Germany
- Gemeinschaftspraxis für Hämatologie und Onkologie Erfurt, Germany
NCT02226861
- Conditions
- Acute Lymphoblastic Leukemia (ALL), Acute Myelogenous Leukemia (AML), Bone Marrow Diseases, +24 more
- Locations
-
- National Institutes of Health Clinical Center, 9000 Rockville Pike Bethesda, Maryland, United States